Skip to content

Genpact G Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect at other companies

Constellium logo
ConstelliumCSTM
$25M+193%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$443M+9,754%
CHE
ChemedCHE
-5,765,900,000%-6,294,644,971pp
Paycom Software logo
Paycom SoftwarePAYC
-$2.73B-65.4%
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
-$62.01M-916%
TFS Financial logo
TFS FinancialTFSL
$27.27M+1,132%

Other financials

Income statement

See full
Revenue$1.3B+6.7%
Gross profit$471.7M+9.9%
Operating income$198.6M+8.1%
Net income$148.0M+13.1%
EPS (diluted)$0.86+17.8%

Balance sheet

See full
Cash & equivalents$578.1M+2.9%
Total debt$1.4B-4.9%
Total equity$2.5B+0.9%
Total assets$5.6B+14.8%

Cash flow

See full
Operating cash flow-$23.5M-158%
CapEx$23.9M+8.9%
Free cash flow-$47.5M-357%

Valuation

See full
Market cap$4.79B-28.5%

Profitability

See full
Gross margin36.3%+0.8pp
Operating margin14.8%-0.1pp
Net margin11%+0.2pp
FCF margin13%+0.6pp

Returns & leverage

See full
Return on equity23.1%+0.9pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Genpact’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Genpact's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Genpact's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect?
Genpact (G) reported cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect of -$259.32M in Q1 2026.